ERICA CRESS: Open Payments
NPI 1205262250 · HARRISVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,467 in 137 payments from 23 companies in 2025. Trend: 2023 $1,997 · 2024 $2,054 · 2025 $2,467
Food & beverage: $2,467
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $416 |
| GlaxoSmithKline, LLC. | 20 | $329 |
| Lilly USA, LLC | 15 | $289 |
| PFIZER INC. | 11 | $204 |
| Novo Nordisk Inc | 9 | $174 |
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| SHIELD THERAPEUTICS INC | 5 | $97 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Lundbeck LLC | 5 | $95 |
Products named: TRELEGY ELLIPTA, MOUNJARO, REXULTI, QULIPTA, NURTEC ODT, VRAYLAR, Ozempic, ACCRUFER.
Industry payments across PA — which companies pay providers there.
